A imunoterapia é uma vertente promissora no combate ao câncer no organismo. Nesta revisão de literatura, é explorado o uso dos fatores de necrose tumoral 4-1BB e OX40 para estimular a ação dos linfócitos T e B contra células tumorais. https://t.co/FFc8AUx
RT @FrontCellDevBio: New Research: Boosting Antitumor Response by Costimulatory Strategies Driven to 4-1BB and OX40 T-cell Receptors: Immun…
New Research: Boosting Antitumor Response by Costimulatory Strategies Driven to 4-1BB and OX40 T-cell Receptors: Immunotherapy explores several strategies to enhance the host immune system’s ability to detect and eliminate cancer cells. The… https://t.co/n